<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Gynecologic Cancer

Research    Gynecologic Cancer

CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes

After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.


Author Cancer Center | Publish Date September 15, 2020
Full Story

Research    Gynecologic Cancer

American Cancer Society Releases Simplified Cervical Cancer Screening Guidelines

Last month the American Cancer Society (ACS) released updated guidelines for cervical cancer screening. The most notable change in guidelines is the changes in the age to begin screening. Per the new guidelines, it is recommended that cervical cancer screening begin at age 25. Previously, the starting age for screening was 21.


Author Cancer Center | Publish Date August 18, 2020
Full Story

CU Cancer Center In the News

OncLive

Dr. Schenk on the Evolving Treatment Landscape in Lung Cancer

news outletOncLive
Publish DateAugust 25, 2020

Erin Schenk, MD, PhD, University of Colorado Cancer Center member, discusses the rapidly evolving treatment landscape in lung cancer.

Full Story
OncLive

Dr. Bunn on Targeting HER3 in NSCLC

news outletOncLive
Publish DateAugust 18, 2020

Paul A. Bunn, Jr, MD, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado, and a 2014 Giant of Cancer Care® in Lung Cancer, discusses potentially targeting HER3 in non–small cell lung cancer (NSCLC).

Full Story
Oncology Learning Network

Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer

news outletOncology Learning Network
Publish DateAugust 10, 2020

“Current guidelines recommend a 28-day course of enoxaparin for thromboprophylaxis after surgery for gynecologic cancer,” wrote Saketh R. Guntupalli, Director of the Division of Gynecologic Oncology, University of Colorado School of Medicine, and colleagues.

Full Story
OncLive

Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC

news outletOncLive
Publish DateJuly 27, 2020

Paul A. Bunn, Jr, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado and a 2014 Giant of Cancer Care® in Lung Cancer, highlights encouraging data with fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-mutant non–small cell lung cancer (NSCLC).

Full Story